149 related articles for article (PubMed ID: 32577157)
1. KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma.
Sobral LM; Sechler M; Parrish JK; McCann TS; Jones KL; Black JC; Jedlicka P
Genes Cancer; 2020; 11(1-2):53-65. PubMed ID: 32577157
[TBL] [Abstract][Full Text] [Related]
2. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1-driven and independent disease-promoting gene expression in fusion-positive Rhabdomyosarcoma.
Sobral LM; Hicks HM; Parrish JK; McCann TS; Hsieh J; Goodspeed A; Costello JC; Black JC; Jedlicka P
Mol Oncol; 2020 Oct; 14(10):2471-2486. PubMed ID: 32697014
[TBL] [Abstract][Full Text] [Related]
3. The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis.
Sechler M; Parrish JK; Birks DK; Jedlicka P
Oncogene; 2017 Jul; 36(29):4150-4160. PubMed ID: 28319067
[TBL] [Abstract][Full Text] [Related]
4. Histone Demethylase
Liu J; Li D; Zhang X; Li Y; Ou J
Onco Targets Ther; 2020; 13():11957-11973. PubMed ID: 33239895
[TBL] [Abstract][Full Text] [Related]
5. The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth.
Parrish JK; McCann TS; Sechler M; Sobral LM; Ren W; Jones KL; Tan AC; Jedlicka P
Oncotarget; 2018 Sep; 9(69):33110-33123. PubMed ID: 30237855
[TBL] [Abstract][Full Text] [Related]
6. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
[TBL] [Abstract][Full Text] [Related]
7. Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation.
Perrone C; Pomella S; Cassandri M; Pezzella M; Giuliani S; Gasperi T; Porrazzo A; Alisi A; Pastore A; Codenotti S; Fanzani A; Barillari G; Conti LA; De Angelis B; Quintarelli C; Mariottini P; Locatelli F; Marampon F; Rota R; Cervelli M
Front Cell Dev Biol; 2023; 11():1061570. PubMed ID: 36755974
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells.
Ouchi K; Miyachi M; Yagyu S; Kikuchi K; Kuwahara Y; Tsuchiya K; Iehara T; Hosoi H
Cancer Cell Int; 2020; 20():192. PubMed ID: 32489328
[TBL] [Abstract][Full Text] [Related]
9. Histone variant H3.3 promotes metastasis in alveolar rhabdomyosarcoma.
Karthik N; Lee JJH; Soon JLJ; Chiu HY; Loh AHP; Ong DST; Tam WL; Taneja R
J Pathol; 2023 Mar; 259(3):342-356. PubMed ID: 36573560
[TBL] [Abstract][Full Text] [Related]
10. KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion.
Liu J; Liang T; Zhangsun W
Int J Biol Macromol; 2019 Apr; 126():318-325. PubMed ID: 30578902
[TBL] [Abstract][Full Text] [Related]
11. The botanical drug PBI-05204, a supercritical CO
Vaccaro S; Rossetti A; Porrazzo A; Camero S; Cassandri M; Pomella S; Tomaciello M; Macioce G; Pedini F; Barillari G; Marchese C; Rota R; Cenci G; Tombolini M; Newman RA; Yang P; Codenotti S; Fanzani A; Megiorni F; Festuccia C; Minniti G; Gravina GL; Vulcano F; Milazzo L; Marampon F
Front Pharmacol; 2022; 13():1071176. PubMed ID: 36532747
[TBL] [Abstract][Full Text] [Related]
12. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
Tombolan L; Poli E; Martini P; Zin A; Millino C; Pacchioni B; Celegato B; Bisogno G; Romualdi C; Rosolen A; Lanfranchi G
BMC Cancer; 2016 Nov; 16(1):886. PubMed ID: 27842508
[TBL] [Abstract][Full Text] [Related]
13. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
14. MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.
Perrone C; Pomella S; Cassandri M; Pezzella M; Milano GM; Colletti M; Cossetti C; Pericoli G; Di Giannatale A; de Billy E; Vinci M; Petrini S; Marampon F; Quintarelli C; Taulli R; Roma J; Gallego S; Camero S; Mariottini P; Cervelli M; Maestro R; Miele L; De Angelis B; Locatelli F; Rota R
Front Oncol; 2022; 12():835642. PubMed ID: 35574376
[TBL] [Abstract][Full Text] [Related]
15. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
[TBL] [Abstract][Full Text] [Related]
16. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
[TBL] [Abstract][Full Text] [Related]
17. Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target.
Yoo J; Jeon YH; Cho HY; Lee SW; Kim GW; Lee DH; Kwon SH
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32354028
[TBL] [Abstract][Full Text] [Related]
18. CD147 Promotes Tumorigenesis via Exosome-Mediated Signaling in Rhabdomyosarcoma.
Fahs A; Hussein N; Zalzali H; Ramadan F; Ghamloush F; Tamim H; El Homsi M; Badran B; Boulos F; Tawil A; Ghayad SE; Saab R
Cells; 2022 Jul; 11(15):. PubMed ID: 35892564
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.
Wu JT; Cheuk A; Isanogle K; Robinson C; Zhang X; Ceribelli M; Beck E; Shinn P; Klumpp-Thomas C; Wilson KM; McKnight C; Itkin Z; Sotome H; Hirai H; Calleja E; Wacheck V; Gouker B; Peer CJ; Corvalan N; Milewski D; Kim YY; Figg WD; Edmondson EF; Thomas CJ; Difilippantonio S; Wei JS; Khan J
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627061
[TBL] [Abstract][Full Text] [Related]
20. KDM3A regulates Slug expression to promote the invasion of MCF7 breast cancer cells in hypoxia.
Ahn HJ; Moon B; Park M; Kim JA
Oncol Lett; 2020 Dec; 20(6):335. PubMed ID: 33123246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
